Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Sep 15, 2026 (25 days ago)

Clear Eyes Redness Relief

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with Hang Tag, 0.5 fl oz (15mL) per dropper bottle, STERILE, Dist. by Medtech Products Inc., Tarrytown, NY 10591. NDC: 67172-797-15

Affected NDC 67172-0797-15

Compare with the code on your package — it is the most precise check available.

Drug: Naphazoline Category: Eye Drops & Ophthalmic

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Clear Eyes Redness Relief
Naphazoline Hydrochloride and Glycerin
NDC 67172-0797
NAPHAZOLINE HYDROCHLORIDE .12 mg/mL; GLYCERIN 2.5 mg/mL Liquid
Ophthalmic
Prestige Brands Holdings, Inc. OTC
Recalling firm
Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0871-2026 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other Naphazoline recalls

See all

Other recalls by Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company

All 2026 recalls
Class I · High risk

Americaine

Chemical Contamination: presence of benzene

Completed Chemical / undeclared Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company NDC 63736-378-02 D-0236-2024